About this trial
Protein malnutrition in critically ill patients is a global concern due to its association with prolonged hospital stays, and higher morbidity rates. Patients who undergo abdominal surgery are particularly vulnerable due to alterations in gastrointestinal function and prolonged fasting. Despite the significance of proper nutrition, the optimal target of protein supplementation remains controversial.
The investigators aimed to evaluate the effects of high protein provision, targeting a protein intake of at least 1.5 g/kg/day for the first 3 days after abdominal surgery, on 6-month mortality.
Eligibility criteria
Qualifiers
Patients admitted after abdominal surgery to our institution's surgical ICU
They were enrolled regardless of the surgical method, either open, laparoscopy, or robotic.
Disqualifiers
aged under 18 years
underwent surgery under local or regional anesthesia
pregnant
readmitted to the ICU due to any cause
Trial design
Treatments tested in this trial
- Active protein supplementation
- Conventional protein supplementation